In conclusion, TRAP-1 potential for cancer-directed therapy is really high, although succinate’s responsibility on TRAP-1 protumoral involvement needs to be further analyzed and cleared, as it may be less relevant than other TRAP-1 targets. The gene discussed is TRAP1; the disease is cancer.